Bath & Body Works (NYSE:BBWI – Get Free Report) had its price objective boosted by analysts at Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 46.98% from the stock’s current price.
Several other analysts have also recently weighed in on the company. UBS Group dropped their price target on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, August 29th. Raymond James dropped their target price on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Barclays upped their price target on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday. Evercore ISI dropped their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research note on Wednesday, August 28th. Finally, Telsey Advisory Group restated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a research report on Monday. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $42.69.
Read Our Latest Stock Analysis on BBWI
Bath & Body Works Stock Performance
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.02. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, equities research analysts expect that Bath & Body Works will post 3.18 EPS for the current fiscal year.
Insider Buying and Selling
In other news, CEO Gina Boswell acquired 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.27% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Bath & Body Works
Large investors have recently added to or reduced their stakes in the business. Anthracite Investment Company Inc. acquired a new stake in Bath & Body Works in the third quarter worth $2,921,000. Principal Financial Group Inc. boosted its position in shares of Bath & Body Works by 328.7% during the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company’s stock worth $34,153,000 after purchasing an additional 820,379 shares in the last quarter. New York State Teachers Retirement System boosted its position in shares of Bath & Body Works by 18.1% during the 3rd quarter. New York State Teachers Retirement System now owns 266,235 shares of the company’s stock worth $8,498,000 after purchasing an additional 40,793 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Bath & Body Works by 404.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 134,544 shares of the company’s stock valued at $4,295,000 after buying an additional 107,868 shares during the period. Finally, Renaissance Technologies LLC increased its position in Bath & Body Works by 152.7% in the 2nd quarter. Renaissance Technologies LLC now owns 901,133 shares of the company’s stock valued at $35,189,000 after buying an additional 544,599 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- How to Find Undervalued Stocks
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What is the Nasdaq? Complete Overview with History
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.